Chang JC - Search Results

1

The lncRNA BORG Drives Breast Cancer Metastasis and Disease Recurrence.

Gooding AJ, Zhang B, Jahanbani FK, Gilmore HL, Chang JC, Valadkhan S, Schiemann WP. Gooding AJ, et al. Among authors: chang jc. Sci Rep. 2017 Oct 5;7(1):12698. doi: 10.1038/s41598-017-12716-6. Sci Rep. 2017. PMID: 28983112 Free PMC article.

2

Selective small molecule Stat3 inhibitor reduces breast cancer tumor-initiating cells and improves recurrence free survival in a human-xenograft model.

Dave B, Landis MD, Tweardy DJ, Chang JC, Dobrolecki LE, Wu MF, Zhang X, Westbrook TF, Hilsenbeck SG, Liu D, Lewis MT. Dave B, et al. Among authors: chang jc. PLoS One. 2012;7(8):e30207. doi: 10.1371/journal.pone.0030207. Epub 2012 Aug 6. PLoS One. 2012. PMID: 22879872 Free PMC article.

3

Studying cancer stem cell dynamics on PDMS surfaces for microfluidics device design.

Zhang W, Choi DS, Nguyen YH, Chang J, Qin L. Zhang W, et al. Sci Rep. 2013;3:2332. doi: 10.1038/srep02332. Sci Rep. 2013. PMID: 23900274 Free PMC article.

4

Cancer stem cells: Role in tumor growth, recurrence, metastasis, and treatment resistance.

Chang JC. Chang JC. Medicine (Baltimore). 2016 Sep;95(1 Suppl 1):S20-S25. doi: 10.1097/MD.0000000000004766. Medicine (Baltimore). 2016. PMID: 27611935 Free PMC article. Review.

5

c-Abl inhibits breast cancer tumorigenesis through reactivation of p53-mediated p21 expression.

Morrison CD, Allington TM, Thompson CL, Gilmore HL, Chang JC, Keri RA, Schiemann WP. Morrison CD, et al. Among authors: chang jc. Oncotarget. 2016 Nov 8;7(45):72777-72794. doi: 10.18632/oncotarget.11909. Oncotarget. 2016. PMID: 27626309 Free PMC article.

6

Mutant p53 dictates the oncogenic activity of c-Abl in triple-negative breast cancers.

Morrison CD, Chang JC, Keri RA, Schiemann WP. Morrison CD, et al. Among authors: chang jc. Cell Death Dis. 2017 Jun 29;8(6):e2899. doi: 10.1038/cddis.2017.294. Cell Death Dis. 2017. PMID: 28661474 Free PMC article.

7

Autophagy inhibition elicits emergence from metastatic dormancy by inducing and stabilizing Pfkfb3 expression.

La Belle Flynn A, Calhoun BC, Sharma A, Chang JC, Almasan A, Schiemann WP. La Belle Flynn A, et al. Among authors: chang jc. Nat Commun. 2019 Aug 14;10(1):3668. doi: 10.1038/s41467-019-11640-9. Nat Commun. 2019. PMID: 31413316 Free PMC article.

8

Inhibition of EZH2 Catalytic Activity Selectively Targets a Metastatic Subpopulation in Triple-Negative Breast Cancer.

Yomtoubian S, Lee SB, Verma A, Izzo F, Markowitz G, Choi H, Cerchietti L, Vahdat L, Brown KA, Andreopoulou E, Elemento O, Chang J, Inghirami G, Gao D, Ryu S, Mittal V. Yomtoubian S, et al. Cell Rep. 2020 Jan 21;30(3):755-770.e6. doi: 10.1016/j.celrep.2019.12.056. Cell Rep. 2020. PMID: 31968251 Free article.

9

Targeting mTOR and DNA repair pathways in residual triple negative breast cancer post neoadjuvant chemotherapy.

Anand K, Patel T, Niravath P, Rodriguez A, Darcourt J, Belcheva A, Boone T, Ensor J, Chang J. Anand K, et al. Sci Rep. 2021 Jan 8;11(1):82. doi: 10.1038/s41598-020-80081-y. Sci Rep. 2021. PMID: 33420229 Free PMC article. Clinical Trial.

10

Molecular heterogeneity of inflammatory breast cancer: a hyperproliferative phenotype.

Nguyen DM, Sam K, Tsimelzon A, Li X, Wong H, Mohsin S, Clark GM, Hilsenbeck SG, Elledge RM, Allred DC, O'Connell P, Chang JC. Nguyen DM, et al. Among authors: chang jc. Clin Cancer Res. 2006 Sep 1;12(17):5047-54. doi: 10.1158/1078-0432.CCR-05-2248. Clin Cancer Res. 2006. PMID: 16951220

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,300 results

Search Page

Filters